Hepcinat Plus tablet contains active agents Daclatasvir and Sofosbuvir.
It is an antiviral medication used to treat chronic hepatitis C virus (HCV) infections.
Hepatitis C infection is a liver disease caused by the hepatitis C virus (HCV).
Uses:
Treatment of chronic hepatitis C virus (HCV) infection.
Therapeutic Effects:
Daclatasvir is a direct-acting antiviral medication that inhibits a protein called NS5A, essential for the replication of the hepatitis C virus.
Sofosbuvir is another direct-acting antiviral medication that inhibits a different protein called NS5B, also essential for the replication of the hepatitis C virus.
Interaction with Other Drugs:
Inform your healthcare provider about all your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products.
Certain medications may interact with Hepcinat plus tablet, reducing effectiveness or causing undesirable side effects.
Storage:
Store at temperature between 20–25°C (68–77°F).
Keep away from moisture, heat, and light.
Do not freeze.
Keep it in its original packaging until it is ready to be used.
Keep out of the reach of children and pets.
How to Consume:
Take Hepcinat plus tablet exactly as prescribed by your doctor.
The recommended dose and dosing schedule may vary depending on your medical condition, age, weight, and other factors.
Take with food.
Swallow the tablet as a whole with a glass of water.
Do not chew, crush, or break the tablet.
Avoid doubling the dose to compensate for a missed dose.
Safety Advices:
Pregnancy: The safety of Hepcinat plus tablet during pregnancy is not well-established. Pregnant women should consult their healthcare provider.
Breastfeeding: It is unknown if Hepcinat plus tablet is excreted in human breast milk. Breastfeeding women should consult a healthcare provider.
Lungs: Patients with pre-existing lung conditions should consult a healthcare provider before starting treatment.
Liver: Hepcinat plus tablets are primarily used to treat hepatitis C. Patients with other liver issues should consult a doctor before taking them.
Alcohol: Drinking alcohol while taking Hepcinat plus tablet is generally not recommended.
Driving: Patients should always monitor their response to the medication and be cautious when driving or operating machinery if they experience any side effects that may impair their ability to do so safely.
Side Effects:
Serious: Liver problems (such as elevated liver enzymes or liver failure), allergic reactions (such as rash or difficulty breathing), abnormal heart rhythms.
Contact your doctor immediately if you experience any unusual symptoms or side effects.
Do not stop medication without first consulting your doctor.
Pregnant and breastfeeding women should consult with a healthcare provider before taking it.
Special caution should be taken when this medication is used in the elderly and pediatrics.
Avoid close contact with an infected person, as this medication lowers the immune system.
Maintain a healthy and balanced diet to support your overall health and well-being.
FAQs:
Can Hepcinat plus tablet be used in patients with kidney disease?
Hepcinat plus tablet can be used in patients with kidney disease, but the dose may need to be adjusted based on the patient's kidney function. Patients with severe kidney disease may require close monitoring during treatment.
Can Hepcinat plus tablet cure hepatitis C completely?
Hepcinat plus tablet can cure hepatitis C in most cases, but the success of the treatment depends on various factors, such as the genotype of the virus, the severity of the liver damage, and the patient's overall health.
Can Hepcinat plus tablet be used in patients with HIV?
Hepcinat plus tablet can be used in patients with HIV who also have hepatitis C. However, the treatment regimen may differ, and additional monitoring may be required.
Can Hepcinat plus tablet be used in patients with cirrhosis?
Hepcinat plus tablet can be used in patients with cirrhosis caused by hepatitis C. The treatment may need to be customized based on the severity of the cirrhosis and other factors. Close monitoring is typically required for patients with cirrhosis.
Can Hepcinat plus tablet be used in elderly patients?
Hepcinat plus tablet can be used in elderly patients, but the treatment plan may need to be adjusted based on factors such as kidney function, liver function, and other medical conditions. Close monitoring may be required for elderly patients during treatment.
